Join Now

Yearly Archives: 2025

Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform

Canary Speech announces it has obtained HITRUST e1 Certification, reinforcing its commitment to cybersecurity related to its voice biomarker technology.

Posted in BioUtah News | Tagged | Comments Off on Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

Posted in BioUtah News | Tagged | Comments Off on Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)

FDA assigns PDUFA target action date of January 5, 2026, for decision on accelerated approval.

Posted in Policy News | Tagged | Comments Off on Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)

GE HealthCare’s Economic Impact Across Utah

GE HealthCare’s Economic Impact Across Utah

Posted in BioUtah News | Tagged | Comments Off on GE HealthCare’s Economic Impact Across Utah

RefloDx Wins Trans Atlantic Angel Grand Prize

RefloDx Wins Trans Atlantic Angel Grand Prize.

Posted in BioUtah News | Tagged | Comments Off on RefloDx Wins Trans Atlantic Angel Grand Prize

Webinar Recap: Immigration Compliance Under Pressure

As immigration enforcement and workplace inspections intensify under the current administration, companies in the life sciences sector, particularly those with manufacturing operations, must be proactive in strengthening compliance. Presented by Ogletree Deakin’s Kathleen Weron on July 1, 2025, this webinar provided an overview of the essential components of I-9 compliance, strategies for responding to audits, […]

Posted in Policy News | Comments Off on Webinar Recap: Immigration Compliance Under Pressure

bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies

bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies

Posted in BioUtah News | Tagged | Comments Off on bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies

DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY

ALPHA-EMITTING RADIOISOTOPE EXPECTED TO PLAY AN ESSENTIAL ROLE IN NEXT-GENERATION TARGETED CANCER THERAPIES

Posted in BioUtah News | Tagged | Comments Off on DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY

2025 BIO International Recap

BioUtah and its Utah consortium made their mark this week at the BIO International Conference, hosting a Utah Pavillion to promote the state’s fast-growing life sciences industry. The conference, held in Boston, MA. drew appproximately 20,000 attendees. The Utah delegation included BioUtah, Utah life sciences companies, the Governor’s Office of Economic Development, the Unversity of […]

Posted in Policy News | Comments Off on 2025 BIO International Recap

Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation

Completion of SAD/MAD trial marks advancement toward further clinical development of HT-4253 in Alzheimer’s and other neurodegenerative diseases.

Posted in BioUtah News | Tagged | Comments Off on Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation

Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services

Strategic Expansion in Salt Lake City Headquarters Will Meet Stringent EU GMP Annex 1 Requirements

Posted in BioUtah News | Tagged | Comments Off on Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services

RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS

AGREEMENT PROVIDES RATIO ACCESS TO NUSANO-PRODUCED RADIOISOTOPES FOR ONCOLOGY DIAGNOSTICS AND THERAPEUTICS

Posted in BioUtah News | Tagged | Comments Off on RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS